Gene symbol: Adora2b

Organism: Rattus norvegicus

Summary: Predicted to enable G protein-coupled receptor activity. Involved in several processes, including negative regulation of collagen biosynthetic process; positive regulation of cAMP-mediated signaling; and positive regulation of interleukin-6 production. Located in cell surface and plasma membrane. Orthologous to human ADORA2B (adenosine A2b receptor). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 29316 Ensembl:ENSRNOG00000002922 AllianceGenome:RGD:2050


GO Annotation


Category Term ID Term description
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001936 Regulation of endothelial cell proliferation
Process GO:0001938 Positive regulation of endothelial cell proliferation
Process GO:0001973 G protein-coupled adenosine receptor signaling pathway
Process GO:0002252 Immune effector process
Process GO:0002263 Cell activation involved in immune response
Process GO:0002274 Myeloid leukocyte activation
Process GO:0002275 Myeloid cell activation involved in immune response
Process GO:0002279 Mast cell activation involved in immune response
Process GO:0002366 Leukocyte activation involved in immune response
Process GO:0002376 Immune system process
Process GO:0002443 Leukocyte mediated immunity
Process GO:0002444 Myeloid leukocyte mediated immunity
Process GO:0002448 Mast cell mediated immunity
Process GO:0002676 Regulation of chronic inflammatory response
Process GO:0002678 Positive regulation of chronic inflammatory response
Process GO:0002682 Regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002694 Regulation of leukocyte activation
Process GO:0002696 Positive regulation of leukocyte activation
Process GO:0002697 Regulation of immune effector process
Process GO:0002699 Positive regulation of immune effector process
Process GO:0002703 Regulation of leukocyte mediated immunity
Process GO:0002880 Regulation of chronic inflammatory response to non-antigenic stimulus
Process GO:0002882 Positive regulation of chronic inflammatory response to non-antigenic stimulus
Process GO:0002886 Regulation of myeloid leukocyte mediated immunity
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0006109 Regulation of carbohydrate metabolic process
Process GO:0006140 Regulation of nucleotide metabolic process
Process GO:0006810 Transport
Process GO:0006887 Exocytosis
Process GO:0006937 Regulation of muscle contraction
Process GO:0006940 Regulation of smooth muscle contraction
Process GO:0006955 Immune response
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007189 Adenylate cyclase-activating G protein-coupled receptor signaling pathway
Process GO:0008015 Blood circulation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0009605 Response to external stimulus
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010574 Regulation of vascular endothelial growth factor production
Process GO:0010575 Positive regulation of vascular endothelial growth factor production
Process GO:0010594 Regulation of endothelial cell migration
Process GO:0010595 Positive regulation of endothelial cell migration
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010632 Regulation of epithelial cell migration
Process GO:0010634 Positive regulation of epithelial cell migration
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010675 Regulation of cellular carbohydrate metabolic process
Process GO:0010701 Positive regulation of norepinephrine secretion
Process GO:0010712 Regulation of collagen metabolic process
Process GO:0010713 Negative regulation of collagen metabolic process
Process GO:0010752 Regulation of cGMP-mediated signaling
Process GO:0010753 Positive regulation of cGMP-mediated signaling
Process GO:0010893 Positive regulation of steroid biosynthetic process
Process GO:0010906 Regulation of glucose metabolic process
Process GO:0014061 Regulation of norepinephrine secretion
Process GO:0016192 Vesicle-mediated transport
Process GO:0017157 Regulation of exocytosis
Process GO:0019216 Regulation of lipid metabolic process
Process GO:0019218 Regulation of steroid metabolic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0019934 cGMP-mediated signaling
Process GO:0019935 Cyclic-nucleotide-mediated signaling
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030808 Regulation of nucleotide biosynthetic process
Process GO:0030810 Positive regulation of nucleotide biosynthetic process
Process GO:0031279 Regulation of cyclase activity
Process GO:0031281 Positive regulation of cyclase activity
Process GO:0031282 Regulation of guanylate cyclase activity
Process GO:0031284 Positive regulation of guanylate cyclase activity
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031347 Regulation of defense response
Process GO:0031349 Positive regulation of defense response
Process GO:0031668 Cellular response to extracellular stimulus
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032418 Lysosome localization
Process GO:0032501 Multicellular organismal process
Process GO:0032642 Regulation of chemokine production
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032755 Positive regulation of interleukin-6 production
Process GO:0032879 Regulation of localization
Process GO:0032940 Secretion by cell
Process GO:0032965 Regulation of collagen biosynthetic process
Process GO:0032966 Negative regulation of collagen biosynthetic process
Process GO:0033003 Regulation of mast cell activation
Process GO:0033005 Positive regulation of mast cell activation
Process GO:0033006 Regulation of mast cell activation involved in immune response
Process GO:0033008 Positive regulation of mast cell activation involved in immune response
Process GO:0033605 Positive regulation of catecholamine secretion
Process GO:0035150 Regulation of tube size
Process GO:0035296 Regulation of tube diameter
Process GO:0035556 Intracellular signal transduction
Process GO:0035588 G protein-coupled purinergic receptor signaling pathway
Process GO:0035590 Purinergic nucleotide receptor signaling pathway
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042311 Vasodilation
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043299 Leukocyte degranulation
Process GO:0043300 Regulation of leukocyte degranulation
Process GO:0043302 Positive regulation of leukocyte degranulation
Process GO:0043303 Mast cell degranulation
Process GO:0043304 Regulation of mast cell degranulation
Process GO:0043306 Positive regulation of mast cell degranulation
Process GO:0043434 Response to peptide hormone
Process GO:0043949 Regulation of cAMP-mediated signaling
Process GO:0043950 Positive regulation of cAMP-mediated signaling
Process GO:0044057 Regulation of system process
Process GO:0044093 Positive regulation of molecular function
Process GO:0044557 Relaxation of smooth muscle
Process GO:0045055 Regulated exocytosis
Process GO:0045321 Leukocyte activation
Process GO:0045576 Mast cell activation
Process GO:0045834 Positive regulation of lipid metabolic process
Process GO:0045921 Positive regulation of exocytosis
Process GO:0045932 Negative regulation of muscle contraction
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045940 Positive regulation of steroid metabolic process
Process GO:0045981 Positive regulation of nucleotide metabolic process
Process GO:0045986 Negative regulation of smooth muscle contraction
Process GO:0046889 Positive regulation of lipid biosynthetic process
Process GO:0046890 Regulation of lipid biosynthetic process
Process GO:0046903 Secretion
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0050433 Regulation of catecholamine secretion
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050679 Positive regulation of epithelial cell proliferation
Process GO:0050727 Regulation of inflammatory response
Process GO:0050729 Positive regulation of inflammatory response
Process GO:0050776 Regulation of immune response
Process GO:0050778 Positive regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050794 Regulation of cellular process
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050810 Regulation of steroid biosynthetic process
Process GO:0050865 Regulation of cell activation
Process GO:0050867 Positive regulation of cell activation
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051339 Regulation of lyase activity
Process GO:0051349 Positive regulation of lyase activity
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051640 Organelle localization
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051656 Establishment of organelle localization
Process GO:0051716 Cellular response to stimulus
Process GO:0051952 Regulation of amine transport
Process GO:0051954 Positive regulation of amine transport
Process GO:0060087 Relaxation of vascular associated smooth muscle
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062013 Positive regulation of small molecule metabolic process
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0071496 Cellular response to external stimulus
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090075 Relaxation of muscle
Process GO:0090257 Regulation of muscle system process
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0140352 Export from cell
Process GO:1900371 Regulation of purine nucleotide biosynthetic process
Process GO:1900373 Positive regulation of purine nucleotide biosynthetic process
Process GO:1900542 Regulation of purine nucleotide metabolic process
Process GO:1900544 Positive regulation of purine nucleotide metabolic process
Process GO:1901652 Response to peptide
Process GO:1901698 Response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1903305 Regulation of regulated secretory pathway
Process GO:1903307 Positive regulation of regulated secretory pathway
Process GO:1903530 Regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1990776 Response to angiotensin
Process GO:1990849 Vacuolar localization
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000300 Regulation of synaptic vesicle exocytosis
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0009986 Cell surface
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0030054 Cell junction
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0045202 Synapse
Component GO:0071944 Cell periphery
Component GO:0098685 Schaffer collateral - CA1 synapse
Component GO:0098978 Glutamatergic synapse
Component GO:0110165 Cellular anatomical entity
Function GO:0001609 G protein-coupled adenosine receptor activity
Function GO:0004888 Transmembrane signaling receptor activity
Function GO:0004930 G protein-coupled receptor activity
Function GO:0038023 Signaling receptor activity
Function GO:0060089 Molecular transducer activity

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-373076 Class A/1 (Rhodopsin-like receptors)
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-417973 Adenosine P1 receptors
RCTM RNO-418038 Nucleotide-like (purinergic) receptors
RCTM RNO-500792 GPCR ligand binding
RCTM RNO-5683826 Surfactant metabolism
WikiPathways WP473 GPCRs, class A rhodopsin-like
WikiPathways WP502 Nucleotide GPCRs
WikiPathways WP5057 Burn wound healing
KEGG rno04015 Rap1 signaling pathway
KEGG rno04020 Calcium signaling pathway
KEGG rno04080 Neuroactive ligand-receptor interaction
KEGG rno04270 Vascular smooth muscle contraction
KEGG rno05034 Alcoholism

Expression profile of Adora2b in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 6.3263907
GSM2685202 MX2 tissue: Myocardium gender: female 6.473851
GSM2685203 MX3 tissue: Myocardium gender: female 5.878951
GSM2685204 MX4 tissue: Myocardium gender: male 6.52899
GSM2685205 DZ1 tissue: Myocardium gender: male 6.913507
GSM2685206 DZ2 tissue: Myocardium gender: male 6.3934546
GSM2685207 DZ3 tissue: Myocardium gender: female 6.804578
GSM2685208 DZ4 tissue: Myocardium gender: female 6.226597
GSM2685209 JJ1 tissue: Myocardium gender: male 5.2046304
GSM2685210 JJ2 tissue: Myocardium gender: female 5.8042035
GSM2685211 JJ3 tissue: Myocardium gender: female 6.01403
GSM2685212 JJ4 tissue: Myocardium gender: male 5.287286
GSM2685213 NG1 tissue: Myocardium gender: male 6.2370133
GSM2685214 NG2 tissue: Myocardium gender: female 5.944693
GSM2685215 NG3 tissue: Myocardium gender: male 5.898235
GSM2685216 NG4 tissue: Myocardium gender: female 6.21731
GSM2685217 YL1 tissue: Myocardium gender: male 6.2245464
GSM2685218 YL2 tissue: Myocardium gender: male 6.7151284
GSM2685219 YL3 tissue: Myocardium gender: female 5.9339504
GSM2685220 YL4 tissue: Myocardium gender: female 5.997702
GSM2685221 QC1 tissue: Myocardium gender: male 6.382153
GSM2685222 QC2 tissue: Myocardium gender: male 6.0875154
GSM2685223 QC3 tissue: Myocardium gender: female 6.2483664
GSM2685224 QC4 tissue: Myocardium gender: female 5.4795923

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.317260822
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.258935803
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.413913211
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.483271823
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.443088589
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.348810676

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 9.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 15.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 14.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 20.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 6.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 9.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 6.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 18.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 4.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 7.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 7.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 12.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 4.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.351465
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.420828
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.450384
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.260328
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.170263
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.277909

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.238
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.026
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 5.388
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 6.351
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 5.863

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.066624961
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 7.879815431
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.244785962

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 85.9
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 13.6
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 71.1
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 56.0
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 23.4
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 47.8
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 12.6
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 13.4
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 164.8
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 23.5
GSM27494 CTL_a (control, 1st replicate) 54.7
GSM27495 CTL_b (control, 2nd replicate) 29.2
GSM27496 CTL_c (control, 3rd replicate) 92.1
GSM27497 CTL_d (control, 4th replicate) 25.1
GSM27498 CTL_e (control, 5th replicate) 33.6
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 40.4
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 15.5
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 11.6
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 31.9
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 7.4
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 73.5
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 74.4
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 76.8
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 17.1
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 137.0
GSM27509 ISCH_a (ischemia, 1st replicate) 184.7
GSM27510 ISCH_b (ischemia, 2nd replicate) 30.8
GSM27511 ISCH_c (ischemia, 3rd replicate) 34.0
GSM27512 ISCH_d (ischemia, 4th replicate) 8.0
GSM27513 ISCH_e (ischemia, 5th replicate) 30.9

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 365.8
GSM30791 baseline control 02 male, 275-300g 432.0
GSM30792 baseline control 03 male, 275-300g 352.4
GSM30793 baseline control 04 male, 275-300g 488.2
GSM30794 baseline control 05 male, 275-300g 465.9
GSM30795 baseline control 06 male, 275-300g 299.9
GSM30796 baseline control 07 male, 275-300g 354.8
GSM30797 baseline control 08 male, 275-300g 408.0
GSM30798 baseline control 09 male, 275-300g 446.0
GSM30799 pain 01 497.0
GSM30800 pain 02 431.3
GSM30801 pain 03 427.5
GSM30802 pain 04 391.1
GSM30803 pain 05 446.4
GSM30804 FC 01 483.6
GSM30805 FC 02 561.5
GSM30806 FC 03 400.9
GSM30807 FC 04 549.4
GSM30808 FC 05 396.2
GSM30809 IFC 01 357.4
GSM30810 IFC 02 377.1
GSM30811 IFC 03 416.4
GSM30812 IFC 04 380.9
GSM30813 IFC 05 379.2
GSM99800 isoflurane 01 male, 275-300g 406.1
GSM99801 isoflurane 02 male, 275-300g 457.4
GSM99802 isoflurane 03 male, 275-300g 391.3
GSM99803 isoflurane 04 male, 275-300g 450.4
GSM99804 isoflurane 05 male, 275-300g 355.5

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 36.1876
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 30.1701
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 21.6015
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 23.7102
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 16.3244
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 19.2497
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 22.6699
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 20.5401
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 39.1069

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 6.17802
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 6.33967
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 5.69986
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 5.9541
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 6.60242
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 6.3703
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 5.6607
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 6.17326
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 5.91523
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 6.48305
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 5.88717
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 5.79455
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 6.48923
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 6.7377
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 5.4472
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 5.24593

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.434398
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.627205
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.262583
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.362126
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 7.580187
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.41306
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.443211
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.454643
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.707934
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 7.753427
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.466227
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.515687
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.694552
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.405529
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.301986
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.268172
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.025551
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.463885
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.516272
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 7.365622
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.538281
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.18285
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.167803
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.243995
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.064648
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.20723
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.529454
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.29403
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.424355
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.177995
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.295165
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.368515
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.319896
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.072589
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.42803
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.395464
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.302621
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.434212
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.313584
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 7.46405
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.32255
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.36237
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.394187
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.0479
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.26616

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 31.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 38.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 31.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 42.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 50.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 34.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 42.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 35.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 27.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 54.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 46.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 40.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 35.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 63.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 42.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 36.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 44.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 58.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 40.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 45.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 50.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 59.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 57.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 55.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 32.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 30.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 48.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 38.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 39.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 57.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 47.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 58.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 48.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 42.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 51.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 25.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.576962
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.266088
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.93681
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.502769

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.126
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0184
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.126
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.099
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.101
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.0277
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0117
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0527
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0103
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.0927
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0364
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.0971

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 40.9
GSM5121 Isoflurane single exposure control-2 41.9
GSM5122 Isoflurane single exposure control-3 40.2
GSM5124 Isoflurane single exposure 1 hr-1 67.3
GSM5126 Isoflurane single exposure 1 hr-2 54.6
GSM5127 Isoflurane single exposure 2 hr-1 33.7
GSM5130 Isoflurane single exposure 2 hr-2 65.2
GSM5131 Isoflurane single exposure 2 hr-3 30.1

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.565183941
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.735917164
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.386385277
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.241113668
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.241647187
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.600763084
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.535422711
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.329095906
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.053738327
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.409228448
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.420106823
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.329095906
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.590789655
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.489042301
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.505773999
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.522142862
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.270899737
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.729305562
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.439002197
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.380366563
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.702702123
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.49636105
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.590219933
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.764586499

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.091064
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.955937
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.992754
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.739765
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.876654
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.951279
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.045482
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.876239
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.715891
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.60342
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.733641
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.944003
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.542523
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.019615
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.732012
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.981958
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.688057
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.077507
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.854093
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.972781
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.645786
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.782233
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.758939
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.750017

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 140.138
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 116.3814

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 92.10133408
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 135.583932
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 169.7558661
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 93.4527603
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 59.770772
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 119.7800694
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 37.59512785
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 148.3138481
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 143.951767
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 186.2019035
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 119.2944195
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 142.286763
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 86.53598642
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 107.180146

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.565183941
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 5.735917164
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.386385277
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 5.241113668
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 6.241647187
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 5.600763084
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.535422711
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 5.329095906
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.053738327
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 5.409228448
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.420106823
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 5.329095906
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.590789655
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 5.489042301
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.505773999
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 5.522142862
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.270899737
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 5.729305562
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.439002197
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 5.380366563
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.702702123
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 5.49636105
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.590219933
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 5.764586499
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 92.10133408
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 135.583932
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 169.7558661
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 93.4527603
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 59.770772
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 119.7800694
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 37.59512785
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 148.3138481
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 143.951767
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 186.2019035
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 119.2944195
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 142.286763
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 86.53598642
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 107.180146

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 34.4
GSM5084 Control 2 34.0
GSM5085 Control 3 39.4
GSM5086 Control 4 39.3
GSM5087 Control 5 25.9
GSM5090 Control 6 39.3
GSM5105 Control 7 38.1
GSM5106 Control 8 46.7
GSM5107 Control 9 41.2
GSM5108 Halothane 10 exposure-1 26.2
GSM5109 Halothane 10 exposures-2 33.9
GSM5110 Halothane 10 exposures-3 45.6
GSM5111 Halothane 5 exposures-1 45.0
GSM5112 Halothane 5 exposures-2 38.6
GSM5113 Halothane 5 exposures-3 32.2
GSM5114 Isoflurane 10 exposures-1 41.7
GSM5115 Isoflurane 10 exposures-2 24.8
GSM5116 Isoflurane 10 exposures-3 32.2
GSM5117 Isoflurane 5 exposures-1 19.6
GSM5118 Isoflurane 5 exposures-2 34.4
GSM5119 Isoflurane 5 exposures-3 43.6
GSM11379 Control 10 45.1
GSM11380 Control 11 29.9
GSM11381 Control 12 45.7

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 18.5542
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 25.0474